title: Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis.
abstract: BACKGROUND
  For patients who suffer from severe chronic pancreatitis, total pancreatectomy can alleviate pain, and islet autotransplantation (IAT) might preserve endocrine function and circumvent the complications of diabetes. Factors that determine success after this operation have not been clearly defined.
  
  
  METHODS
  From 2000 to 2004, 45 total or subtotal pancreatectomies with IAT were performed. Patient characteristics, narcotic usage and insulin requirements were recorded at routine followup. Narcotic usage was standardized by conversion to morphine equivalents (MEs). Univariate and multivariate statistical analyses were performed to determine factors associated with insulin and narcotic independence.
  
  
  RESULTS
  Forty-five patients (30 women, 15 men), with a mean age of 39 years (range 16 to 62 years) underwent total or completion (n=41) or subtotal (n=4) pancreatectomies with IAT. Forty percent of patients were insulin free after a mean followup of 18months (range 1 to 46months). Factors associated in univariate analyses with insulin independence included female gender (p=0.004), lower body weight (kg) (p=0.04), more islet equivalents per kg body weight (IEQ/kg) transfused (<0.05), lower mean insulin requirement for the first 24hours postoperation (p=0.002), and lower mean insulin requirement at discharge (p=0.0005). A multiple logistic regression using gender, body mass index, and IEQ/kg identified female gender as the only notable variable associated with insulin independence. There was a notable reduction (p < 0.0001) of postoperative MEs (mean 90 mg) compared with preoperative MEs (mean 206 mg) for the entire cohort; 58% of patients are narcotic independent. In the subset of patients with>5months followup (n=32), 23 (72%) are narcotic free, with a substantial decrease in ME usage (p=0.01).
  
  
  CONCLUSIONS
  The likelihood of glycemic control after IAT is related to both patient characteristics and islet cell mass. Based on these data, more islet cells may be required for insulin independence than previously thought.
authors.affiliation: Pancreatic Disease Center, Department of Surgery, University of Cincinnati, Cincinnati, OH 45219, USA.
authors.forename: Syed A
authors.initials: SA
authors.lastname: Ahmad
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Lowy
authors.forename: Curtis J
authors.initials: CJ
authors.lastname: Wray
authors.forename: David
authors.initials: D
authors.lastname: D'Alessio
authors.forename: Kywran A
authors.initials: KA
authors.lastname: Choe
authors.forename: Laura E
authors.initials: LE
authors.lastname: James
authors.forename: Andreas
authors.initials: A
authors.lastname: Gelrud
authors.forename: Jeffrey B
authors.initials: JB
authors.lastname: Matthews
authors.forename: Horacio L R
authors.initials: HL
authors.lastname: Rilo
mesh_terms: D000293:Adolescent; D000328:Adult; D000701:Analgesics, Opioid / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D010180:Pancreatectomy / Q000379:methods*; D050500:Pancreatitis, Chronic / Q000188:drug therapy / Q000601:surgery*; D012307:Risk Factors; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D000701:Analgesics, Opioid; D007004:Hypoglycemic Agents; D007328:Insulin